Seeking Alpha

MDR, GPS among premarket losers

|About: AnaptysBio, Inc. (ANAB)|By:, SA News Editor

AnaptysBio (NASDAQ:ANAB) -73% after Q3 results and lead drug flunks dermatitis study.

Therapix Biosciences (NASDAQ:TRPX) -40% on mutual decision with Destiny Biosciences Global to discontinue negotiations on the previously announced proposed merger.

Red Lion Hotels (NYSE:RLH) -34% after Q3 results.

Medifast (NYSE:MED) -32% after Q3 results.

Teradata (NYSE:TDC) -25% after Q3 results.

Green Dot (NYSE:GDOT) -18% after Q3 results.

McDermott International (NYSE:MDR) -14%.

Affimed N.V. (NASDAQ:AFMD) -11% after pricing stock offering.

Bionano Genomics (NASDAQ:BNGO) -11% after Q3 results.

Turtle Beach (NASDAQ:HEAR) -9% after Q3 results.

The Gap (NYSE:GPS) -8% after slashing guidance and CEO exit.

Agios Pharmaceuticals (NASDAQ:AGIO) -6% on pricing of $256M equity offering.

Try Seeking Alpha PREMIUM for unlimited analysis on ANAB